| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.46 | 0.0007 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.2 | 0.0007 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.008 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |